Tag | Content |
---|
EnhancerAtlas ID | HS062-10416 |
Organism | Homo sapiens |
Tissue/cell | GM18486 |
Coordinate | chr21:16235890-16237820 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
FOXP1 | MA0481.2 | chr21:16237306-16237318 | TCCTGTTTACTT | - | 6.07 | Foxo1 | MA0480.1 | chr21:16237306-16237317 | TCCTGTTTACT | + | 6.32 | HNF1A | MA0046.2 | chr21:16237559-16237574 | GATAAATTATTAACT | + | 6.58 | HNF1B | MA0153.2 | chr21:16237560-16237573 | ATAAATTATTAAC | - | 6.11 | Stat6 | MA0520.1 | chr21:16236488-16236503 | CTTTTCCTGAGAAAG | + | 6.38 | ZIC4 | MA0751.1 | chr21:16236735-16236750 | GCCCAGCAGGGGGCA | - | 6.04 |
|
| Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
SE_34076 | chr21:16235783-16237136 | HCC1954 | SE_34076 | chr21:16237158-16237686 | HCC1954 | SE_35466 | chr21:16235557-16237918 | HepG2 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH21I014863 | chr21 | 16235401 | 16238045 |
|
Enhancer Sequence | TTATTTCTCT CTTTACATAA GACAAATATT TTACTACATT GTGTACTATA ATAATCTTTC 60 TCATGGCCAA CACAGAAATA TTAGCATCTA CCAAATATGG TTAAATCCTC AAAGCCTACT 120 TATAAAGCAA AAGCAGCACT GGAAATTGAC ATCACTTACA TTTAGTCACA TTTTCAAAAG 180 AGCATGATTA ATGAAACAGA AGTGTTCTCA TGGAGCGTGT GCACCATGTG CTAGTGACAG 240 TTATATCAGA ACGAACTACA TGTAGCATTT ATCTTCCTTT TGCTCTGGTA TCTCCCGAGT 300 GAAACGCTTG GGTGTGTATG AAAAGCATAG GGAGAATGAC AACTCATTTG GTATTGACTT 360 GGCCTTTGTC CCAGCTCTCT CTTACATCAT CAACCCCTTC CTCATCTCTG CTGTCACTGA 420 CTTTGAGAAA GCACATGGTT CAGCCATTTG ACATCCTCTC TGTAAGACCA GGGATGAGTC 480 TGCTATGCGT AGCTCTGTTT ATTAAAACCT CAATTTTAAG AAGGTTACCA TTCTACATAA 540 AACCCTTGAC CTCTCAGAGT TAGTGGTATG AGCCTAAAAG TTGCCAGGAC ATGCTAAACT 600 TTTCCTGAGA AAGAGTCCAG TCAACAATTT TATGACAATC CTTCTGACCT GAGCTTTGCT 660 TAATACCATC AAATAAGTCA CAGGACAGTC AGGAGATTGG AAATGTATCA CTTGATGAGG 720 TTTTTCAGAT TGATAACACG AGGGTAAGCA ACTGTGTCAT CCAGGAGGCT CCAAAGTCCA 780 GGGTCCATTC AGGGCCAACT ACAGCAGTGC CCCTTCCTAA GTCCAGGCCA TTCACACCAA 840 CCGAAGCCCA GCAGGGGGCA GCTTCCCAAA GCTAAATCTA AAAAGACCAT AGCCAGCCCA 900 GCTGAAAGTC CCAGGAAAAG GCAATGTTGC CTAACAGTCA TGAGACAGCT GGAAAAGTCC 960 CTGCACCTGA CACACACTGT TACAGACAGT GCTGCCTCAT AGACGTGTAG AAGGCACATC 1020 AGGGAGAGTG TCGGGGTCAG GCCAGAAACT TCACATTAAA TCAGGGAGGA TTTGTTTGGG 1080 GCTCACATTT AGACAGAGAA CAAAGACTTC TCTGTCATTT TTGTAGTTTT GTTCATTTGT 1140 ATTTGAAAAT AGCAGTTCTC TCTCTGGCCT GACTGCATCC CTTTGATGGT AACTGAAGCT 1200 TTCCATTGCA GCGGTGCTCC TGACGGGGGC GACATTGAAC CTGCTCAGGG CTCAGGGCTC 1260 CTCTTCCCGG CTCTGTGGCC TCCCCGAACA TGAGTAACAC TATGGCCTGC AAAGATAGGA 1320 CTTAATTGTC CTTAAAAGGA AAAATGCCTG CATGACCAGA GTTGGACCAA GCCAGAACAG 1380 GAGCCCCTGA GAAGTGCTAG GTACATTTTT AACAGTTCCT GTTTACTTTC CATAGGAGAT 1440 TATGAGAAGA ACACAAGAGC ACATTTATAA GTAGTTTTCA TGATTCATGT TATCACTGAA 1500 ACCAGATGCT ATTCTGAATC AAACAACCCT GAAGTGATGT GCAATTCTAA TATCTGCTTA 1560 ATTAATCAAA ATATTCATTA ATACGTAAGA AAACACATTC TGTTTGTGTT TTAGAGTACA 1620 CATTTATCAC ATGCTCATAA ATACTTAAAT ACAGGAGGTA TGCTTGGCAG ATAAATTATT 1680 AACTTTTCAG AGATCTGCAG ATTTTAGAAA GTTTTGGGGG GAAATTAAAT TTTAATAAAA 1740 CAGCATTTTA CTTAATTACA GAAAAATCAA ATAAAATTAT TTTCTAGATT CTGAAAGAAA 1800 AACAAATAGA TTATAAACTG TAAATGCCCT TTGTCTTATG ATAACCTTGC TAGCTTTAGT 1860 AATTGTATAA TATTATGAAC CTTGGGAAAC AGTGCAAAGC ATCAAAAATC TTATATTAAC 1920 ATATATATTG 1930
|